Kirti Bansidhar Maheshwari

Title: Kirti Bansidhar Maheshwari: Innovator in Modified Release Oral Dosage Forms

Introduction

Kirti Bansidhar Maheshwari is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release oral dosage forms. His innovative approach has led to advancements that enhance the efficacy and convenience of medication delivery.

Latest Patents

Maheshwari holds a patent for a modified release oral dosage form using a co-polymer of polyvinyl acetate. This invention comprises a once-a-day modified release oral dosage form that includes granules or pellets. These granules can either be compressed into a tablet or filled inside a capsule. The pellet features a core of active ingredient coated on non-pareil seeds, with a rate-controlling functional coating of co-polymer of polyvinyl acetate. Additionally, there may be an intermediate separating coating between the core and the functional coating layer. This innovative formulation aims to improve patient compliance and therapeutic outcomes.

Career Highlights

Kirti Bansidhar Maheshwari is currently associated with Astron Research Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in the research and development sector.

Collaborations

Maheshwari collaborates with talented professionals in his field, including Shashank Bababhai Patel and Kamala Sultansingh Yadav. Their combined efforts contribute to the advancement of pharmaceutical research and innovation.

Conclusion

Kirti Bansidhar Maheshwari's contributions to the field of modified release oral dosage forms exemplify the importance of innovation in pharmaceuticals. His work not only enhances medication delivery but also improves patient outcomes.